WallStreetZenWallStreetZen

NASDAQ: SONN
Sonnet Biotherapeutics Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SONN

Based on 1 analyst offering 12 month price targets for Sonnet Biotherapeutics Holdings Inc

Min Forecast
$20.00+526.96%
Avg Forecast
$20.00+526.96%
Max Forecast
$20.00+526.96%

Should I buy or sell SONN stock?

Based on 1 analyst offering ratings for Sonnet Biotherapeutics Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SONN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SONN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their SONN stock forecasts and price targets.

SONN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-07

1 of 1

Forecast return on equity

Is SONN forecast to generate an efficient return?

Forecast return on assets

Is SONN forecast to generate an efficient return on assets?

Company
N/A
Industry
47.5%

SONN earnings per share forecast

What is SONN's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$3.46

SONN revenue forecast

What is SONN's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.0M+0%
SONN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SONN revenue growth forecast

How is SONN forecast to perform vs Biotechnology companies and vs the US market?

Company
0%
Industry
79.33%
Market
10.78%
SONN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SONN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SONN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SONN$3.19$20.00+526.96%Strong Buy
LSTA$2.50$32.00+1,180.00%Strong Buy
PASG$6.93$59.25+755.60%Strong Buy
QTTB$1.81$15.00+728.73%Hold
CTXR$1.23$6.00+387.80%Strong Buy
View Top Biotech Stocks

Sonnet Biotherapeutics Holdings Stock Forecast FAQ

Is Sonnet Biotherapeutics Holdings Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SONN) stock is to Strong Buy SONN stock.

Out of 1 analyst, 1 (100%) are recommending SONN as a Strong Buy, 0 (0%) are recommending SONN as a Buy, 0 (0%) are recommending SONN as a Hold, 0 (0%) are recommending SONN as a Sell, and 0 (0%) are recommending SONN as a Strong Sell.

If you're new to stock investing, here's how to buy Sonnet Biotherapeutics Holdings stock.

What is SONN's earnings growth forecast for 2025-2025?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.

Sonnet Biotherapeutics Holdings's earnings in 2025 is -$13,556,225.

In 2025, SONN is forecast to generate -$23,370,058 in earnings, with the lowest earnings forecast at -$23,370,058 and the highest earnings forecast at -$23,370,058.

What is SONN's revenue growth forecast for 2025-2025?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings's forecast annual revenue growth rate of 0% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.78%.

Sonnet Biotherapeutics Holdings's revenue in 2025 is $1,000,000.

In 2025, SONN is forecast to generate $6,754,352 in revenue, with the lowest revenue forecast at $6,754,352 and the highest revenue forecast at $6,754,352.

What is SONN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SONN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 47.5%.

What is SONN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SONN price target, the average SONN price target is $20.00, with the highest SONN stock price forecast at $20.00 and the lowest SONN stock price forecast at $20.00.

The Wall Street analyst predicted that Sonnet Biotherapeutics Holdings's share price could reach $20.00 by Apr 7, 2026. The average Sonnet Biotherapeutics Holdings stock price prediction forecasts a potential upside of 526.96% from the current SONN share price of $3.19.

What is SONN's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: SONN) Sonnet Biotherapeutics Holdings's current Earnings Per Share (EPS) is -$7.07. In 2025, SONN's EPS is forecast to hit -$3.46 (min: -$3.46, max: -$3.46).

What is SONN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SONN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.